BCM
BDSX icon

Bridgeway Capital Management’s Biodesix BDSX Stock Holding History

Bridgeway Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Buy
26,035
+15,000
+136% +$222K 0.01% 817
2026
Q1 		$160K Buy
+11,035
New +$137K ﹤0.01% 1069
2025
Q3 		– Sell
-6,851
Closed -$38.7K – 1203
2025
Q2 		$38.7K Hold
6,851
– – ﹤0.01% 1144
2025
Q1 		$85.7K Sell
6,851
-12,865
-65% -$247K ﹤0.01% 1066
2024
Q4 		$603K Buy
19,716
+5,490
+39% +$162K 0.01% 776
2024
Q3 		$506K Buy
14,226
+4,973
+54% +$171K 0.01% 857
2024
Q2 		$283K Sell
9,253
-2,230
-19% -$63.7K 0.01% 976
2024
Q1 		$328K Buy
11,483
+23
+0.2% +$787 0.01% 1021
2023
Q4 		$422K Buy
11,460
+2,460
+27% +$77.2K 0.01% 981
2023
Q3 		$297K Sell
9,000
-2,500
-22% -$69.4K 0.01% 1012
2023
Q2 		$283K Buy
11,500
+2,530
+28% +$75.8K 0.01% 1061
2023
Q1 		$334K Buy
8,970
+5,220
+139% +$214K 0.01% 984
2022
Q4 		$173K Sell
3,750
-1,250
-25% -$34K ﹤0.01% 1117
2022
Q3 		$127K Buy
5,000
+2,500
+100% +$96.4K ﹤0.01% 1229
2022
Q2 		$82K Sell
2,500
-1,750
-41% -$56.9K ﹤0.01% 1247
2022
Q1 		$144K Sell
4,250
-1,000
-19% -$65.4K ﹤0.01% 1224
2021
Q4 		$555K Buy
+5,250
New +$686K 0.01% 951

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Bridgeway Capital Management's BDSX Position: Q2 2026 in Review

Bridgeway Capital Management increased its Biodesix (BDSX) stake by 136% in Q2 2026, buying an estimated $222K and bringing the position to 26,035 shares worth $587K. The position accounts for 0.01% of the portfolio, ranked #817.

Bridgeway Capital Management first reported a position in BDSX in Q4 2021 and has held it in 17 quarters since. The position peaked at $603K in Q4 2024. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Bridgeway Capital Management held 26,035 shares of Biodesix worth $587K as of Q2 2026.
  • Bridgeway Capital Management bought 15,000 Biodesix shares in Q2 2026, an estimated $222K.
  • Biodesix made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #817 holding.
  • Bridgeway Capital Management first reported a position in Biodesix in Q4 2021 and has held it in 17 quarters since.
  • Bridgeway Capital Management's Biodesix position peaked at $603K in Q4 2024.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.